"Naked" radiopharmaceuticals

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue SUPPL. 2, 2006, Pages

  Wallner, Paul E ^a  

^a 21ST CENTURY ONCOLOGY   (United States)

Author keywords

Iodine 131; Radioistope; Radiopharmaceuticals

Indexed keywords

DRUG PRODUCTS; MEDICAL APPLICATIONS; ONCOLOGY; PHYSIOLOGY; RADIOTHERAPY;

ANATOMIC PLACEMENT; IODINE-131; RADIOPHARMACEUTICALS;

RADIOISOTOPES;

ANTIBIOTIC AGENT; CHROMIUM PHOSPHATE P 32; IODINE 131; LEXIDRONAM SAMARIUM SM 153; PHOSPHORUS 32; RADIOPHARMACEUTICAL AGENT; SAMARIUM 153; SODIUM IODIDE; STRONTIUM 89; YTTRIUM 90;

ARTICLE; BONE PAIN; CHRONIC MYELOID LEUKEMIA; CLINICAL RESEARCH; DIAGNOSTIC IMAGING; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG MEGADOSE; HUMAN; JOINT EFFUSION; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RADIATION PROTECTION; RADIATION SAFETY; THYROID CANCER; THYROID DISEASE; TREATMENT INDICATION; TUMOR; UNSPECIFIED SIDE EFFECT;

IODINE RADIOISOTOPES; PHOSPHORUS RADIOISOTOPES; RADIOISOTOPES; RADIOPHARMACEUTICALS; SAMARIUM; STRONTIUM RADIOISOTOPES; THYROID DISEASES;

EID: 33748464133     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.056     Document Type: Article

References (16)

1. Coover L.R., Silberstein E.B., Kuhn P.J., et al. Therapeutic I-131 in outpatients: A simplified method conforming to the Code of Federal regulations, title 10, part 35.75. J Nucl Med 41 (2000) 1868-1875
2. Barbaro D., Boni G., Meucci G., et al. Radionuclide treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnants ablation and possible role of iodine content in l-thyroxine in the outcome of ablation. J Endocinol Metab 88 (2003) 4110-4115
3. Potter M.E., Partridge E.E., Shingleton H.M., et al. Intraperitoneal chromic phosphate in ovarian cancer: Risks and benefits. Gynecol Oncol 32 (1989) 314-318
4. 32P) in women with early ovarian carcinoma after comprehensive surgical staging. Obstet Gynecol 79 (1992) 993-997
5. Spanos W.J., Day T., Jose B., et al. Use of P-32 in stage III epithelial carcinoma of the ovary. Gynecol Oncol 54 (1994) 35-39
6. Spencer T.R., Marks R.D., Fenn J.O., et al. Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinoma. Cancer 63 (1989) 2434-2437
7. Order S.E., Siegel J.A., Lustig R.A., et al. A new method of delivering radioactive cytoxic agents in solid cancers. Int J Radiat Oncol Biol Phys 30 (1994) 715-720
8. Firusian N., and Dempke W. An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. Cancer 85 (1999) 980-987
9. Siegel H.J., Luck J.V., Siegel M., et al. Advances in radionuclide therapeutics in orthopedics. J Am Acad Orthop Surg 12 (2004) 55-64
10. Soroa V.E., del Huerto Velazquez Espeche M., Giannone C., et al. Effects of radiosynovectomy with p-32 colloid therapy in hemophilia and rheumatoid arthritis. Cancer Biotherm Radiopharm 20 (2005) 344-348
11. Finlay, Mason M.D., Shelley M., et al. Radioisotopes for the palliation of metastatic bone cancer: A systematic review. Lancet Oncol 6 (2005) 353-354
12. Hellman R.S., and Krasnow A.Z. Radionuclide therapy for palliation of pain due to osteoblastic metastases. J Palliat Med 1 (1998) 277-283
13. Janjan N.A. Radiation for bone metastases: Conventional techniques and the role of systemic radiopharmaceuticals. Cancer 80 (1997) 1628-1645
14. McEwan A.J. Use of radionuclides for the palliation of bone metastases. Semin Radiat Oncol 10 (2000) 103-114
15. Saarto T., James R., Tenhunen M., et al. Palliative radiotherapy in the treatment of skeletal metastases. Eur J Pain 6 (2002) 323-330
16. Silberstein E.B. Teletherapy and radiopharmaceutical therapy of painful bone metastases. Semin Nucl Med 35 (2005) 152-158